Draper_Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine effi cacy: secondary analysis of data from a phase 3 randomised controlled trial

This content is restricted to site members. If you are an existing user, please log in. New users may register - Register now

International Union of Immunological SocietiesUniversity of South AfricaInstitute of Infectious Disease and Molecular MedicineElizabeth Glazer Pediatric Aids FoundationStellenbosch University